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E-mail address: Gunter.Schneider@ki.se (G. SchneiRemF is a polyketide cyclase involved in the biosynthesis of the aromatic pentacyclic metabolite
resistomycin in Streptomyces resistomyciﬁcus. The enzyme is a member of a structurally hitherto
uncharacterized class of polyketide cyclases. The crystal structure of RemF was determined by
SAD and reﬁned to 1.2 Å resolution. The enzyme subunit shows a b-sandwich structure with a topol-
ogy characteristic for the cupin fold. RemF contains a metal binding site located at the bottom of the
predominantly hydrophobic active site cavity. A zinc ion is coordinated to four histidine side chains,
and two water molecules in octahedral ligand sphere geometry, highly unusual for zinc binding sites
in proteins.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The biosynthesis of aromatic polyketides requires the coordi-
nated action of several enzymes, a type II polyketide synthase
(PKS) that elongates the polyketide chain from malonyl-CoA units,
an ACP molecule that carries the growing polyketide and addi-
tional PKS components such as ketoreductases and polyketide cyc-
lases (for recent reviews see [1–4]). A particular striking example
of the interplay between polyketide biosynthetic enzymes is the
biosynthesis of resistomycin, an unusual pentacyclic aromatic
polyketide produced by Streptomyces resistomyciﬁcus [5]. Contrary
to most biosynthetic pathways of polycyclic aromatic polyketides
where chain elongation and cyclisation occur sequentially by the
action of individual enzymes, the resistomycin carbon skeleton is
formed by a concerted action of the heterodimeric polyketide syn-
thase RemAB, the ACP carrier molecule RemC and at least three dif-
ferent cyclases, RemI, RemF, and RemL (Scheme 1) [6]. Indeed it
has been suggested that these molecules form amultienzyme com-
plex that controls chain elongation and regiospeciﬁcity of the cyc-
lisation steps and guides correct folding of the pentacyclic, discoid
ring structure of bis-nor-resistomycin [6]. In a subsequent step, thischemical Societies. Published by E
der).unstable intermediate is converted into resistomycin by the action
of RemG, a methyltransferase that catalyzes an unusual tandem
methylation [7].
Polyketide cyclases can be classiﬁed into several sequence fam-
ilies that represent different folds and potentially different enzy-
matic mechanisms [1,6]. The SnoaL type catalyzes ring closure by
internal aldol condensation using acid/base chemistry [8,9]. Albeit
very different in three-dimensional structure to SnoaL the tetrace-
nomycin aromatase/cyclase also catalyzes ring closure using acid/
base chemistry [10]. The tetracenomycin F2 cyclase from S. glau-
cescens is a member of a third sequence family, characterized by
a ferredoxin-like fold and which does not use catalytic acid/bases
in its mechanism [11]. Based on sequence comparisons the three
putative cyclases essential for the biosynthesis of resistomycin,
namely RemI, RemF and RemL have been assigned to three of the
ten sequence families [6]. RemI is related to the cyclases repre-
sented by tetracenomycin aromatase/cyclase with the characteris-
tic ‘‘helix-grip” fold [10]. RemL and RemF belong to two different
cyclase families that are not yet structurally characterized. We
here report the crystal structure of the dimeric polyketide cyclase
RemF. The enzyme subunit is folded into a cupin domain that con-
tains an unusual octahedral Zn2+ binding site in a large hydropho-
bic pocket that may represent the active site. The metal ion could
act as a Lewis acid in the aldol condensation reaction catalyzed by
RemF, reminiscent of class II aldolases.lsevier B.V. All rights reserved.
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Scheme 1. Steps in resistomycin biosynthesis. It is presently not known which of
the ring closure steps is catalyzed by RemF, but it has been suggested [6] that all
three cyclases RemIFL are required to direct folding of the polyketide chain into a
discoid ring structure. SAM denotes S-adenosyl-methionine. The scheme was
adopted from the proposal by Hertweck and colleagues [7].
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2.1. Expression and puriﬁcation
The DNA coding for Remf from S. resistomyciﬁcus was obtained
from C. Hertweck, Jena, Germany. The sequence coding for the full
length enzyme (Met1-Lys143) was subcloned using the ligation
independent cloning strategy into the expression vector pNIC28-
Bsa4 (GenBank Accession No. EF198106), that contains an N-termi-
nal hexahistidine tag and a TEV-protease cleavage site. The
construct was transformed into the expression strain BL21-Gold
(DE3) (Stratagene) containing the pRARE2 plasmid from the Roset-
ta2 strain (Novagen). Large scale expressions of the construct were
performed in Terriﬁc Broth supplemented with 50 lg/ml kanamy-
cin and 34 lg/ml chloramphenicol. Cells were grown at +37 C to
an OD600 of 1.0. Gene expression was induced at +18 C by addi-
tion of 0.5 mM isopropyl-b-D-thiogalactopyranoside (IPTG) and
continued at +18 C overnight. Cells were harvested by centrifuga-
tion at 4000g for 15 min, the medium was discarded and the pel-
lets were stored at 20 C. The cell pellets were resuspended into
buffer containing 50 mM sodium phosphate, pH 7.4, 500 mM NaCl,
10% glycerol, 0.5 mM tris(2-carboxyethyl) phosphine (TCEP),
25 mM imidazole, 0.2 mg/ml lysozyme, 20 lg/ml DNAse, 1 mM
MgCl2, and 1 tablette Complete EDTA-free protease inhibitor cock-
tail (Roche)/50 ml of buffer. Lysis was performed by pulse sonica-
tion with 15 s burst and 10 s pause for 3 min. Cell debris was
removed by centrifugation at 10 000g for 30 min, the supernatant
was ﬁltered and combined with 2 ml Ni-NTA agarose (Qiagen)
equilibrated with a buffer containing 50 mM sodium phosphate,
pH 7.4, 500 mM NaCl, 10% glycerol, 0.5 mM TCEP, 25 mM imidaz-
ole, and mixed by shaking overnight at +4 C. The protein was
eluted from Ni-NTA with buffer containing 200 mM imidazole.
Fractions containing RemF were combined and the buffer was
changed by dialysis to TEV cleavage buffer consisting of 50 mM
Tris, pH 8, 0.5 mM EDTA and 1 mM DTT. After dialysis TEV protease
was added to the RemF solution in a 1:50 ratio (w:w) and the
cleavage was performed ﬁrst at +20 C for 16 h, and continuedfor an additional two hours at +30 C. After cleavage the reaction
mixture was equilibrated for 60 min at +4 C with 1 ml Ni-NTA in
20 mM Tris, pH 8, 150 mM NaCl, and 1 mM DTT. The slurry was
packed in a column and the ﬂow through containing the untagged
RemF was collected. The buffer in the fraction containing RemF
was changed using PD-10 columns (GE Healthcare) to 20 mM Tris,
pH 8, 150 mM NaCl, 1 mM DTT, concentrated and 5% glycerol were
added.
2.2. Selenomethionine-substituted RemF
Selenomethionine-substituted RemF was produced in M9 min-
imal medium. The cells were grown at +37 C and solid amino acids
were added (100 mg/l Thr, Phe, Lys, 50 mg/l Ile, Leu, Val and 60 mg
L-Se-Met) once the culture had reached the log phase. Incubation
at +37 C was continued for another 15 min, the temperature was
then lowered to +18 C and IPTG was added to ﬁnal concentration
of 0.5 mM. Expression was continued at +18 C for 17 h after which
the cells were pelleted and the selenomethionine-substituted pro-
tein was puriﬁed using the same protocol as for native RemF. The
construct of RemF carries four methionine residues, three methio-
nine residues derived from the sequence of the native protein and
one methionine at position -1 as a result of the cloning procedure.
2.3. Crystallization, data collection and structure determination
Crystals of both native (10 mg/ml) and selenomethionine-
substituted (3.5 mg/ml) RemF were grown at +20 C using the
hanging drop vapour-diffusion method with a well solution con-
sisting of 1 M tri-sodium citrate and 0.1 M sodium cacodylate, pH
6.5. Crystals were also grown in the presence of 200 mM ZnCl2, un-
der otherwise identical conditions. Before freezing in liquid nitro-
gen, crystals were brieﬂy soaked in a cryoprotectant solution
composed of the respective well solution complemented with
25% ethylene glycol. Diffraction data from native RemF crystals
were collected to 1.2 Å at the European Synchrotron Radiation
Facility (ESRF) at beamline ID14-4 and a single-wavelength anom-
alous diffraction experiment using selenomethionine-substituted
RemF was carried out at beamline BM16 at the ESRF. Another
SAD dataset was collected from a crystal of SeMet substituted pro-
tein grown in the presence of 0.2 M ZnCl2 at the wavelength 1.28 Å,
the K absorption edge of the zinc ion (Table 1).
Crystals of the monoclinic space group contain two RemF mol-
ecules in the asymmetric unit, and all eight selenium sites were lo-
cated from the SAD dataset using the program SOLVE [12].
Automated chain tracing as implemented in the program RESOLVE
[13] was used to build the initial model. Several cycles of rebuild-
ing with ARP/wARP [14] and COOT [15] resulted in a complete
model for the selenomethionine-substituted RemF. This model
was used as a template for the molecular replacement with the
program MOLREP [16] using the high-resolution dataset of the
wild-type protein in space group P2221. Reﬁnement was per-
formed with REFMAC5 [17]. After several cycles of isotropic re-
straint reﬁnement, addition of water molecules and anisotropic
B-factor reﬁnement in the ﬁnal round, REFMAC5 converged with
R/Rfree factors of 16.0%/18.5%, respectively. Several cycles of aniso-
tropic reﬁnement using SHELXL [18] and all reﬂections included
resulted in the ﬁnal model with a crystallographic R-factor of
12.8%. This model contains 142 residues, 209 water molecules
and one metal ion. Several residues were modeled with double
conformations for the side chains. The Ramachandran plot shows
that 98.4% of the residues are in the most favored region, and three
non-glycine residues are in the additional allowed region. Data and
model statistics are summarized in Table 1.
Multiple sequence alignments were made with MULTALIN [19]
and multiple structural alignments with PROMALS3D [20] and
Fig. 1. (A) Cartoon illustrating the structure of RemF. The blue sphere indicates the
location of the metal binding site. (B) The RemF dimer. The two subunits are
coloured in red and green, respectively. The b-strand exchange, crucial to dimer
formation, is highlighted by an arrow.
Table 1
Data collection and reﬁnement statistics.
Dataset Wild-type SeMet Zn-SeMeta
Beamline ID14-4 (ESRF) BM16 (ESRF) BM16 (ESRF)
Wavelength (Å) 0.975 0.9787 1.282
Space group P2221 P21 P21
Resolution range (Å) 47.9–1.15 (1.21–1.15) 48.6–2.1 (2.21–2.1) 48.6–2.0 (2.11–2.0)
Unit cell parameters (Å) 4.5, 47.9, 96.9 34.4, 97.1, 47.9 34.4, 97.3, 47.7
b () 90.0 91.8 92.0
Rmerge 0.063 (0.137) 0.055 (0.077) 0.071 (0.144)
I/rI 20.6 (5.2) 30.1 (13.1) 23.4 (8.6)
Completeness (%) 92.6 (62.5) 89.9 (56.3) 97.0 (82.1)
Redundancy 7.0 (3.5) 6.5 (4.2) 6.9 (4.9)
No. of unique reﬂections 53620 (5150) 16506 (1491) 20594 (2495)
R/Rfree (%)b 12.7/16.7 – 19.3/24.4
No. of protein atoms (B-factor, Å2) 1183 (13.0) – 2277 (23.9)
No. of solvent atoms (B-factor, Å2) 209 (32.1) – 257 (33.9)
No. of metal ions (B-factor, Å2) 1 (7.7) – 2 (17.0)
r.m.s. Deviations
Bond lengths (Å) 0.010 – 0.011
Bond angles () 1.439 – 1.34
Ramachandran plot
Preferred (%) 92.9 94.3
Additionally allowed (%) 7.1 5.7
Outliers (%) 0 0
a Zn-SeMet denotes the crystals grown in an excess of 200 mM ZnCl2
b The ﬁnal R-factor obtained by reﬁnement with SHELXL [18] is 0.128 using all reﬂections.
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RemF was carried out using the program SPASM [22] with the
coordinates of the four histidine ligands of the Zn2+ site ion in
RemF as search motif and potential hits were inspected manually
at the graphics display. Figures were prepared using Pymol [23].
The crystallographic data have been deposited with the Protein
Data Bank, accession codes 3HT1 and 3HT2.
3. Results and discussion
3.1. RemF contains a cupin fold
The RemF molecule consists of 11 b-strands that form the two
antiparallel b-sheets (b2, b3, b4, b11, b6, b9 and b5, b10, b7, b8)
of a jellyroll b-sandwich with a topology typical for the cupin-bar-
rel fold [23] (Fig. 1A). The C-terminal residues 128–132 form a 310
helix which breaks at Pro135 and the last residues 135–141-fold
into a short a-helix. These two helices cover the outer surface of
the b-sheet 1. A multiple sequence alignment of the 75 closest
homologues of RemF shows considerable variation in length for
the part of the polypeptide chain following strand b11; the major-
ity of sequences are about 20 amino acids shorter than RemF indi-
cating that this helical segment is missing in these proteins. The C-
terminal of RemF is located rather far from the putative active site,
and a direct involvement in catalysis therefore appears less likely.
However, it could contribute to stability, since its packing to the
core of the protein is very tight.
RemF forms a dimer in the crystal. Se-methionine substituted
enzyme contains the dimer in the asymmetric unit, whereas in
crystals of native RemF the dimer is formed between the subunit
in the asymmetric unit and another molecule related by crystallo-
graphic symmetry (x, y, z). Approximately 1800 Å2 (21% of the
total surface area) is buried in the interface between the two sub-
units, and residues involved in subunit–subunit interactions are
evenly distributed along the chain, i.e. residues 2–8 (b1), 29–30,
34–43 (b4), 58–66 (b6), 72–95 (b8, b9), and 108–116 (b11). One
intriguing feature of this protein family, also seen in RemF, is the
b-strand swapping in the dimer; the ﬁrst b-strand (residues 3–7)
of one subunit is part of the b-sheet of the second subunit and runs
antiparallel to strand b9 (Fig. 1B).3.2. Comparison to other cupins
The cupin fold is found in a wide variety of enzymes, non-enzy-
matic seed storage proteins as well as many hypothetical proteins
of unknown function [24]. A search of the Protein Data Bank using
the program DALI [25] and the RemF coordinates found a number
of structures with the same fold. The highest score (Z = 17) was ob-
tained from a comparison to a protein of unknown function from
Thermotoga maritima [26], resulting in an rmsd of 1.2 Å for
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Data Bank that shows any signiﬁcant overall sequence identity
(26%) to RemF. Sequence identities to all other cupins of known
three-dimensional structure are beyond the twilight zone of se-
quence alignments (<18% identity).
The multiple structural alignment of the eight best hits from the
Dali search with RemF (Supplementary material) reveals only four
invariant residues, three histidines (His53, His55, His95) and one
glycine residue (Gly66, RemF numbering). All of these residues
are part of the characteristic cupinmotifs. Gly66 is located between
strands b6 and b7, and is most likely conserved for structural
reasons. The histidine residues are part of the metal binding site.
3.3. The metal binding site in RemF
During model building it became clear that RemF contains a
metal binding site. An X-ray ﬂuorescence emission spectrum ob-
tained from crystals of the wild-type protein revealed the presence
of Ni2+ and smaller amounts of Zn2+, whereas no signals for other
transition metals such as Mn2+, Co2+, Cu2+ or Fe2+ were found.
The X-ray ﬂuorescence scan of crystals of selenomethionine-
substituted RemF obtained in the presence of 200 mM ZnCl2
showed only a signal for zinc, and a complete dataset at a wave-
length of 1.28 Å, the zinc K absorption edge (Table 1) was collected.
The anomalous difference electron density map shows a strong po-
sitive difference density at the metal binding site, demonstrating
that the bound metal in these crystal is Zn2+ (Fig. 2). The structure
of RemF derived from data obtained from wild-type crystals was
therefore modeled with a Ni2+ ion in the metal site, whereas in
the protein structure obtained from selenomethionine-substituted
crystals the metal ion was assigned as Zn2+. We attribute the pres-
ence of Ni2+ to metal exchange during puriﬁcation using the Ni2+ –
nitrilo-triacetic acid column; partial exchange of the endogenous
metal ion by Ni2+ as an artifact of the puriﬁcation protocol has been
observed also in other cupins [27]. Aside from the differences in
chemical nature of the metal ion, the metal binding sites in the
two models are, within the error limits of the analysis, identical
with respect to ligand geometry and distances.
The metal binding site in RemF shows octahedral coordination
geometry, with four histidine side chains (His53, His55, His59
and His95) as protein ligands to the metal ion. Two water mole-
cules complete the ligand sphere of the zinc ion (Fig. 2). The aver-
age metal–nitrogen distance is 2.08 Å, and the metal–water
distance is 2.13 Å. The Zn2+ ligands are part of the conserved metal
binding motifs GX5HXH(X)3,4EX6G and GX5PXGX2HX3N character-
istic for the cupin fold [28]. In RemF they are modiﬁed to
GX5HXHX3HX6G and GX5PXGX2HX3T (deviations from the canoni-
cal cupin ﬁngerprints indicated in bold). The replacement of Glu
with His in motif 1 is not only observed in RemF, but in a number
of other sequences of the cupin superfamily.Fig. 2. The zinc binding site in RemF. Part of an anomalous difference electron denZinc binding sites in proteins usually show tetrahedral or pen-
tagonal coordination geometries, and less than 5% of all zinc sites
in proteins contain six ligands, indicating an octahedral coordina-
tion sphere of the metal ion ([29,30], http://tanna.bch.ed.ac.uk/).
None of these octahedral Zn binding sites contain a four His motif.
This motif appears to be very unusual for octahedral metal binding
sites in general as a search for similar arrangements of four histi-
dine side chains as part of octahedral ligand geometries in metal-
loproteins resulted in only two more hits, the protein TM1459 of
unknown function from T. maritima [26], and chain L of the reac-
tion center from Rhodobacter sphaeroides [31]. However, none of
these proteins contains zinc. The metal site in TM1469 is very sim-
ilar to that observed in RemF, with four histidine side chains and
two water molecules, but the metal had been assigned as a manga-
nese ion. The other case, the L-chain of the reaction center, features
Fe2+ as the metal ion in an octahedral coordination with four histi-
dine ligands and two oxygen atoms from glutamic acid residues as
additional ligands.
3.4. Putative active site
Genetic evidence suggested that RemF participates in cyclisa-
tion of the pentacyclic polyketide core of resistomycin, although
it is yet unknown which of the ring closure step(s) is catalyzed
by this enzyme (Scheme 1). Due to the inherent instability of the
polyketide intermediates potential substrates were not available
for co-crystallization experiments. The metabolic intermediate
resulting from the series of cyclisation steps catalyzed by RemF,
RemL and RemI is bis-nor-resistomycin, and we explored by mod-
eling if the active site of RemF is of sufﬁcient size to accommodate
this compound or its precursors.
The metal binding site in RemF is located in a rather large
hydrophobic pocket, accessible from the solvent and it is possible
to ﬁt a model of bis-nor-resistomycin or its precursors into this
pocket, without invoking any large movements of protein side
chains. The ring system can be positioned into this cleft in various
different orientations, and details of ligand–protein interactions
can therefore not be determined unambiguously. However the
pocket is of sufﬁcient size to ﬁt such large ligands, and protein
atoms can form favorable interactions to atoms of the polyketide
core (Fig. 3). For instance, residues Phe42, Trp57, Ile61, Phe97,
Phe107, and Val109 that line this pocket can participate in hydro-
phobic contacts to the ring system, and two oxygen atoms of the
ligands can be placed within coordination distance to the metal
ion replacing the two water molecules. Alternative binding modes,
that suppose an indirect interaction of the ligand with the metal
mediated via one or two of these water molecules can however
not be excluded. In chemical terms the ring closure steps in the
biosynthesis of resistomycin can be described by a series of aldol
condensations. If indeed RemF is a polyketide cyclase these modelssity map, calculated from data collected at the Zn2+ K-edge, is shown at 10r.
Fig. 3. Stereoview of a model of a putative remF – bis-nor resistomycin complex.
L. Silvennoinen et al. / FEBS Letters 583 (2009) 2917–2921 2921suggest potential mechanistic similarities of RemF to class II aldol-
ases where a zinc ion acts as a Lewis acid in aldol condensation
reactions [32].
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